Introduction Maternal colonisation with group B Streptococcus (GBS) is a well recognised cause of neonatal sepsis. Colonisation of the infant at delivery results in invasive disease in 1–2% of neonates with a 5% mortality. Routine antenatal screening is recommended and prophylaxis offered to colonised women. We report a case of recurrent mid‐trimester fetal death in utero , caused by GBS chorioamnionitis, and a subsequent successful pregnancy achieved with intermittent amoxicillin therapy from 12 weeks’ gestation. Case report A 33‐year‐old previously well woman presented with recurrent mid‐term fetal death in utero as a result of chorioamnionitis caused by GBS ( Streptococcus agalactiae ). The first pregnancy spontaneously miscarried at 19 weeks’ gestation. There was no history of premature rupture of membranes. No antenatal screening had been undertaken and vaginal colonisation with GBS had not been established. At the time of delivery there was evidence of maternal sepsis with an elevated white cell count of 33.8 × 10 9 /L (4.0–10.0 × 10 9 /L) with left shift and toxic changes. The fetus was macerated but anatomically normal and consistent with gestational age of approximately 20 weeks. The placenta was grossly normal but microscopically showed considerable bacterial infection of the
Australian and New Zealand Journal of Obstetrics and Gynaecology – Wiley
Published: Aug 1, 2004
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera